Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release
Results from the GUARDIAN trial
Karen Klatte, MD*,
Bernard R. Chaitman, MD, FACC*,2,
Pierre Theroux, MD, FACC
,2,
Jeffrey A. Gavard, PhD*,
Karen Stocke, MBA*,
Steven Boyce, MD, FACC
,2,
Claus Bartels, MD
,2,
Birgit Keller, MS||,2,
Andreas Jessel, MD||,2 for the GUARDIAN Investigators1
* St. Louis University Health Sciences Center, St. Louis, Missouri, USA
Montreal Heart Institute, Montreal, Quebec, Canada
Washington Heart Center, Washington, DC, USA
Med. Universitatsklinik, Herzchirurgische Klinik, Luebeck, Germany
|| Aventis Pharmaceuticals, Inc., Bridgewater, New Jersey, USA

View larger version (17K):
[in a new window]
|
Figure 3 Receiver operating characteristic curve predicting six-month mortality at various levels of peak creatine kinase-myocardial band (CK-MB) enzyme ratios. ULN = upper limits of normal.
|
|
Copyright © 2001 by the American College of Cardiology Foundation.